TrialDiabetes care2002

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

Giancarlo Viberti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.